Clinical Trial Modernization

Our Work · Working GroupS

Clinical Trial Modernization

This working group is addressing the evolving landscape of clinical trial conduct in the modern era through proof-of-concept projects, publications, and more.

Modernizing clinical research through responsible innovation and collaboration

Finding a modern approach

As tools such as artificial intelligence advance, clinician scientists have new opportunities to modernize clinical research. Responsible implementation requires collaboration across multiple stakeholder groups. H&VC’s Clinical Trial Modernization Working Group is addressing this evolving landscape through publications, proof-of-concept projects, and educational materials designed to streamline all stages of clinical research and support improved patient outcomes.

Leadership

Meet the group’s leadership

David J. Cohen
David J. Cohen, MD, MSc, MSCAI

Cardiovascular Research Foundation / St. Francis Hospital, New York, NY / Roslyn, NY

Jeffrey J. Popma
Jeffrey J. Popma, MD

Cardiovascular Research Foundation, New York, NY

Sreekanth Vemulapalli
Sreekanth Vemulapalli, MD

Duke Clinical Research Institute, Durham, NC

Bobby Yeh
Bobby Yeh, MD

Beth Israel Deaconess Medical Center, Boston, MA

Learn more from this working group

Publication · 2026

Clinical Trial Modernization · Tricuspid

In this preplanned Tricuspid Valve Academic Research Consortium-2 (TVARC-2) consensus document, we seek to utilize the definitions and principles described in TVARC-1 to create Chapter 2. Specifically, TVARC-2 proposes trial designs and endpoints to inform future transcatheter tricuspid valve intervention investigation.

Apple Podcasts

↗

Spotify

↗

Watch the video

↗

Podcast · 17 min

Video · 17 min

Clinical Trial Modernization

Modernizing the Data Infrastructure for Clinical Research

Michael Mack and Amy Abernathy discuss how to streamline research and accelerate timelines in order to provide timely care.

Read the publication

↗

↗

Watch the video

↗

Long-Term Follow-Up of Patients with Heart Valve Devices Workshop

June 21, 2024
Course Directors: Changfu Wu, Rosann White

Presentation: 12:05 PM – 12:10 PM
Overview of FDA-Mandated Long-Term Postapproval Studies for Heart Valve Devices
Lisa Plummer, RN, MSN

Co-sponsored by

Watch the video

Explore other working groups

Find out what other H&VC working groups have developed.

Working group

A global group of leading experts working to advance knowledge and share best practices in the prevention and treatment of rheumatic heart disease.

Explore the group

Rheumatic Heart Disease

Working group

A number of ongoing efforts to build knowledge, develop consensus, and ignite innovation in congenital, adult congenital, and pediatric heart disease.

Explore the group

Congenital and Pediatric Heart Disease

Subscribe to our newsletter

Get news and updates from the Heart & Valve Collaboratory.

By subscribing, you agree to our Privacy Policy.